Achillion spikes on positive, early-stage hep C data; Active Biotech wins 10M euro payday; GenVec taps Cynthia Collins as new CEO;

 @FierceBiotech: Celery extract shrinks difficult breast cancer tumor in mouse trials. Article | Follow @FierceBiotech

 @JohnCFierce: Scrap drug patents in favor of drug prizes? Vermont's Bernie Sanders draws up another fun bill with no hope of success. More | Follow @JohnCFierce

> Shares of Achillion Pharmaceuticals ($ACHN) spiked 10% this morning after the biotech reported clean safety results and positive efficacy signs from a Phase Ib study of its hep C drug ACH-2684. Release

> Sweden's Active Biotech snagged a 10 million euro milestone from Ipsen after investigators enrolled the 600th patient in their Phase III study of the prostate cancer drug tasquinimod. Release

> Cynthia Collins, the former CEO of Sequoia Pharmaceuticals, has been named chief executive of Gaithersburg, MD-based GenVec. Release

> Switzerland's S.L.A. Pharma AG announced statistically significant top-line data from their Phase II study of four doses of Nalcol, a novel oral formulation of naloxone for opioid induced constipation in patients with persistent non-cancer pain. Release

> Maryland officials are touting the economic benefits that flowed from 1,775 clinical trials hosted in the state over a decade. Story

> NovaBay enrolled its first patient in a Phase IIb adenoviral conjunctivitis study. Report

Pharma News

 @FiercePharma: Potentially good for Hep C drugmakers: CDC calls for all boomers to get tested. Could ID 800K cases--Bloomberg. More | Follow @FiercePharma

> How does pharma's CEO pay rank? Article

> FDA review backs Xarelto for big new use in ACS patients. Story

> Pfizer recalled 653,000 bottles of smelly Advil. More

Medical Devices News

 @FierceMedDev: The FDA is planning a summit on how to build a better hospital glucose sensor. Block off June 25 on your calendars. More | Follow @FierceMedDev

 @MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce

> Covidien recalls Roticulator staplers. Story

> ResMed hits the 1,000-patient milestone for apnea device study. More

> Biotronik's drug-coated balloon wows with promising 6-month results. Article

Biotech IT News

 @RyanMFierce: Click on #FBITchat & tune in for my chat with @Medidata's @CaptainClinical on innovations in clinical trials tomorrow. More | Follow @RyanMFierce

> Accelrys snaps up discovery software from Scynexis. More

> Ex-Apple CEO forecasts tech-driven change in medicine. News

> Startup Knode takes off with pharma fuel. Story

And Finally… Vermont Senator Bernie Sanders, the Senate's only practicing socialist, has introduced a new bill that would scrap drug patents, rewarding developers instead with multibillion-dollar prizes. Story

 

Suggested Articles

A new clinical hold is the latest setback for Solid Biosciences and the development of its gene therapy for Duchenne muscular dystrophy.

VBI's Sci-B-Vac protected twice as many people than GSK's Engerix-B did after the second dose.

The notice comes weeks after Amgen revealed it was retreating from its East Coast neuroscience operations.